Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amneal Pharmaceuticals Inc
(NY:
AMRX
)
5.870
UNCHANGED
Last Price
Updated: 7:00 PM EST, Dec 26, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amneal Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
Next >
Amneal Expands Leadership Team with Appointment of Senior Leaders in Quality and Regulatory
October 31, 2022
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal to Report Third Quarter 2022 Results on November 4, 2022
October 06, 2022
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal Launches First Biosimilar with ALYMSYS® (bevacizumab-maly) in the United States
October 03, 2022
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal Appoints Gustavo Pesquin as Executive Vice President, Chief Commercial Officer – Specialty
September 06, 2022
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal Seeks FDA Approval For Its Parkinson's Candidate
September 01, 2022
Via
Benzinga
Amneal Pharma Posts Mixed Q2 Earnings, Cuts Profit Outlook For 2022
August 05, 2022
Via
Benzinga
Recap: Amneal Pharmaceuticals Q2 Earnings
August 05, 2022
Amneal Pharmaceuticals (NYSE:AMRX) reported its Q2 earnings results on Friday, August 5, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 31, 2022
Gainers
Via
Benzinga
Amneal Announces Submission of New Drug Application to the U.S. FDA for IPX203 for the Treatment of Parkinson’s Disease
August 31, 2022
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal supports Congress’ efforts to ensure essential medicines are Made in America
August 22, 2022
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal launches 4 new Generic products, including Vasopressin single-dose
August 11, 2022
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Recap: Amneal Pharmaceuticals Q1 Earnings
May 04, 2022
Amneal Pharmaceuticals (NYSE:AMRX) reported its Q1 earnings results on Wednesday, May 4, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
August 11, 2022
On Thursday, 22 companies reached new 52-week lows.
Via
Benzinga
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
August 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Amneal Reports Second Quarter 2022 Financial Results
August 05, 2022
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal Pharmaceuticals's Earnings: A Preview
August 04, 2022
Amneal Pharmaceuticals (NYSE:AMRX) is set to give its latest quarterly earnings report on Friday, 2022-08-05. Here's what investors need to know before the announcement. Analysts estimate that Amneal...
Via
Benzinga
Earnings Scheduled For August 5, 2022
August 05, 2022
Companies Reporting Before The Bell • Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million.
Via
Benzinga
Amneal Appoints Deborah M. Autor to Board of Directors
August 03, 2022
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal to Report Second Quarter 2022 Results on August 5, 2022
July 08, 2022
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal Releases 2021 Corporate Responsibility Report Highlighting Continued ESG Impact and Integration
June 07, 2022
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal Launches LYVISPAH® (baclofen) for Spasticity Related to Multiple Sclerosis and Other Spinal Cord Disorders
June 01, 2022
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal Achieves Third U.S. Biosimilar Approval with FYLNETRA™ (pegfilgrastim-pbbk)
May 27, 2022
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal to Participate at the 2022 Jefferies Healthcare Conference
May 24, 2022
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal to Participate at Upcoming Investor Conferences in May
May 13, 2022
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints
May 04, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Amneal Reports First Quarter 2022 Financial Results
May 04, 2022
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal Pharmaceuticals's Earnings Outlook
May 03, 2022
Amneal Pharmaceuticals (NYSE:AMRX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
21 Stocks Moving in Monday's Pre-Market Session
April 18, 2022
Gainers Mullen Automotive, Inc. (NASDAQ: MULN) shares rose 16.2% to $2.51 in pre-market trading. Mullen Automotive announced plans to begin construction for EV battery pack...
Via
Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More
April 14, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Amneal Scores Second US Biosimilars Approval With Alymsys In Oncology
April 14, 2022
The FDA approved Amneal Pharmaceuticals Inc (NYSE: AMRX) Biologics License Application (BLA) for bevacizumab-maly, a biosimilar referencing Avastin. The product...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.